BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 25, 2015
View Archived Issues
FDA gives orphan drug designation to intranasal diazepam
Read More
BHV-0223 shows favorable pharmacokinetics in phase I trial
Read More
ObsEva and Kissei sign development and commercialization agreement for KLH-2109
Read More
Baxalta seeks clearance for first-in-human study of BAX-826 extended half-life rFVIII treatment
Read More
PD-L1 shows potential as a prognostic biomarker for meningioma
Read More
Roivant Sciences licenses PDE4 inhibitor E-6005 from Eisai
Read More
Symberix awarded multiple SBIR grants to develop microbiome-targeted drugs
Read More
ZAI Lab and Hanmi to develop novel EGFR-targeted therapy for lung cancer in China
Read More
Cellceutix gets FDA orphan drug designation for Kevetrin, completes enrollment in Prurisol study
Read More
AGTC's achromatopsia gene therapies granted orphan drug designations
Read More
Phase III trial of ofatumumab in follicular lymphoma to be stopped early due to lack of efficacy
Read More
PEGylated Mdm2 antagonist prodrug shows encouraging antitumor activity
Read More
Kitov Pharmaceuticals announces initial public offering
Read More
Green Cross seeks U.S. approval for IVIG-SN for primary immunodeficiency diseases
Read More
Zutectra receives positive CHMP opinion for use after liver transplantation
Read More
Entresto receives E.U. approval
Read More
FDA approves Portrazza for metastatic squamous NSCLC
Read More
Women's health specialist Pivot Pharmaceuticals completes acquisition of IndUS Pharmaceuticals
Read More
Angion's CYP11B2 inhibitor shows potential for CKD in animal models
Read More
FDA decides not to approve Indivior's naloxone nasal spray for opioid overdose
Read More
Sunshine Lake Pharma patents 5-HT reuptake inhibitors
Read More
ESSA Pharma starts phase I/II trial of prostate cancer candidate EPI-506
Read More
Orion develops GABA-B receptor PAMs
Read More
University of Colorado discloses TLR2 agonists
Read More
Bristol-Myers Squibb reports GPR40 modulators
Read More
Lycera presents ROR-gamma agonists
Read More
FDA approves Opdivo for previously untreated BRAF V600 wild-type advanced melanoma
Read More
University of Ulster describes apelin receptor agonists
Read More
Microvesicle hsa-microRNA-223-3p, a promising biomarker to differentiate OA and RA
Read More
Multikinase inhibitor RXDX-105 well tolerated to date in phase I trial in solid tumors
Read More